Fewer pills, more flexibility in dosing: Roches new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF)

29th June 2017 Uncategorised 0

Roche

More: Fewer pills, more flexibility in dosing: Roches new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF)
Source: MDlinx